Abstract

English

Highlights

  • The c-kit+ cardiac stem cells represent the most extensively characterised subset of cardiac stem cell pool

  • Among various types identified as cardiac stem cell (CSC) such as side population (SP) cells, cardiac progenitor cells (CPCs), Sca-1+cells, cardiosphere cells and Isl1+cells include c-kit+ cells, which are still the most extensively characterised CSCs4

  • Contrary to previous notion about the heart as a postmitotic organ, the existence of endogenous cardiac stem cell (eCSC) has been confirmed in various recent studies[1,2,3,5,7,8]

Read more

Summary

Discussion

The author has referenced some of his own studies in this review. The protocols of these studies have been approved by the relevant ethics committees related to the institution in which they were performed. Neonate CHD patient’s right atrial tissue represent a rich source of ckit+ cardiac progenitor cells/CDCs The occurrence of resident CPCs in human myocardium from young age subjects has been investigated in some recent studies[11,29] Such studies may explore the prospects of cell-based therapies for various nonischaemic heart diseases. One such study claimed to be unique of its type is by Mishra et al.[11] who identified right atrial (RA) tissues from neonate patients of CHDs to have the highest number of c-kit+ CPCs compared with infants and children These CPCs were shown to have the highest proliferation and differentiation potential as evident from in vitro immunostaining­results for Ki67 and Nkx2.5 expression. Since the study is based on SCF overexpression and many forms of tumours such as gynaecological tumours, breast cancer, SCLC and Ewing’s sarcoma are known to coexpress c-kit receptors and SCF36–39, the metastatic predisposition to various forms of tumours modulated by ­c-kit/SCF axis cannot be ruled out

Introduction
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.